MX2010011015A - Tienopirimidinas. - Google Patents
Tienopirimidinas.Info
- Publication number
- MX2010011015A MX2010011015A MX2010011015A MX2010011015A MX2010011015A MX 2010011015 A MX2010011015 A MX 2010011015A MX 2010011015 A MX2010011015 A MX 2010011015A MX 2010011015 A MX2010011015 A MX 2010011015A MX 2010011015 A MX2010011015 A MX 2010011015A
- Authority
- MX
- Mexico
- Prior art keywords
- thieno
- carboxylic acid
- amino
- pyrimidine
- acid amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008017853A DE102008017853A1 (de) | 2008-04-09 | 2008-04-09 | Thienopyrimidine |
PCT/EP2009/002112 WO2009124653A2 (de) | 2008-04-09 | 2009-03-23 | Thienopyrimidine |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010011015A true MX2010011015A (es) | 2010-11-22 |
Family
ID=40765631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010011015A MX2010011015A (es) | 2008-04-09 | 2009-03-23 | Tienopirimidinas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110028472A1 (zh) |
EP (1) | EP2260044A2 (zh) |
JP (1) | JP2011518132A (zh) |
KR (1) | KR20110010721A (zh) |
CN (1) | CN102015724A (zh) |
AR (1) | AR071586A1 (zh) |
AU (1) | AU2009235729A1 (zh) |
BR (1) | BRPI0911364A2 (zh) |
CA (1) | CA2720878A1 (zh) |
DE (1) | DE102008017853A1 (zh) |
EA (1) | EA201001576A1 (zh) |
IL (1) | IL208066A0 (zh) |
MX (1) | MX2010011015A (zh) |
WO (1) | WO2009124653A2 (zh) |
ZA (1) | ZA201007979B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010265164A1 (en) * | 2009-06-22 | 2012-02-09 | Merck Patent Gmbh | Alkoxy-thienopyrimidines as TGF-beta receptor kinase modulators |
NZ599597A (en) | 2009-10-30 | 2013-05-31 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
ES2667049T3 (es) | 2010-02-05 | 2018-05-09 | Merck Patent Gmbh | Derivados de heteroaril-[1,8]naftiridina |
CA2790613C (en) | 2010-02-22 | 2018-01-02 | Merck Patent Gmbh | Hetarylaminonaphthyridines |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
MX344600B (es) | 2011-06-27 | 2016-12-20 | Janssen Pharmaceutica Nv | Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina. |
FR2988722B1 (fr) * | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
RU2657540C2 (ru) | 2012-06-26 | 2018-06-14 | Янссен Фармацевтика Нв | Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств |
RU2667058C2 (ru) | 2012-07-09 | 2018-09-14 | Янссен Фармацевтика Нв | Ингибиторы фермента фосфодиэстеразы 10 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
AU4972900A (en) | 1999-04-08 | 2000-11-14 | Arch Development Corporation | Use of anti-vegf antibody to enhance radiation in cancer therapy |
WO2005080377A1 (ja) * | 2004-02-20 | 2005-09-01 | Kirin Beer Kabushiki Kaisha | TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物 |
WO2006090094A1 (en) * | 2005-02-28 | 2006-08-31 | Vernalis R & D Ltd | Pyrimidothiophene compounds for use as hsp90 inhibitors |
DE102005013621A1 (de) * | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituierte 2-Aryl(Hetaryl)-5-aminothieno[2,3-d]pyrimidin-6-carbonsäureamide, Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika |
US20080004271A1 (en) * | 2006-01-17 | 2008-01-03 | Mckenna Jeffrey M | Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith |
WO2008020622A1 (fr) * | 2006-08-17 | 2008-02-21 | Kyorin Pharmaceutical Co., Ltd. | NOUVEAU COMPOSÉ DE THIÉNO[2,3-d]PYRIMIDINE |
-
2008
- 2008-04-09 DE DE102008017853A patent/DE102008017853A1/de not_active Withdrawn
-
2009
- 2009-03-23 CN CN2009801122450A patent/CN102015724A/zh active Pending
- 2009-03-23 WO PCT/EP2009/002112 patent/WO2009124653A2/de active Application Filing
- 2009-03-23 US US12/937,031 patent/US20110028472A1/en not_active Abandoned
- 2009-03-23 CA CA2720878A patent/CA2720878A1/en not_active Abandoned
- 2009-03-23 AU AU2009235729A patent/AU2009235729A1/en not_active Abandoned
- 2009-03-23 JP JP2011503357A patent/JP2011518132A/ja active Pending
- 2009-03-23 EA EA201001576A patent/EA201001576A1/ru unknown
- 2009-03-23 BR BRPI0911364A patent/BRPI0911364A2/pt not_active Application Discontinuation
- 2009-03-23 EP EP09731280A patent/EP2260044A2/de not_active Withdrawn
- 2009-03-23 MX MX2010011015A patent/MX2010011015A/es not_active Application Discontinuation
- 2009-03-23 KR KR1020107025024A patent/KR20110010721A/ko not_active Application Discontinuation
- 2009-04-08 AR ARP090101244A patent/AR071586A1/es unknown
-
2010
- 2010-09-07 IL IL208066A patent/IL208066A0/en unknown
- 2010-11-08 ZA ZA2010/07979A patent/ZA201007979B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE102008017853A1 (de) | 2009-10-15 |
EA201001576A1 (ru) | 2011-04-29 |
US20110028472A1 (en) | 2011-02-03 |
JP2011518132A (ja) | 2011-06-23 |
AR071586A1 (es) | 2010-06-30 |
BRPI0911364A2 (pt) | 2015-12-29 |
IL208066A0 (en) | 2010-12-30 |
EP2260044A2 (de) | 2010-12-15 |
KR20110010721A (ko) | 2011-02-07 |
AU2009235729A1 (en) | 2009-10-15 |
WO2009124653A3 (de) | 2009-12-03 |
CN102015724A (zh) | 2011-04-13 |
WO2009124653A2 (de) | 2009-10-15 |
CA2720878A1 (en) | 2009-10-15 |
ZA201007979B (en) | 2011-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2401936T3 (es) | 5-Ciano-tienopiridinas para el tratamiento de tumores | |
MX2010011015A (es) | Tienopirimidinas. | |
ES2400728T3 (es) | Derivados de triazol | |
AU2009275544B2 (en) | Imidazothiadiazoles derivatives | |
AU2007315374B2 (en) | Triazabenzo[e]azulene derivatives for the treatment of tumors | |
US20120101095A1 (en) | Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |